Filing Details

Accession Number:
0001181431-14-024288
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-17 18:27:44
Reporting Period:
2014-06-16
Filing Date:
2014-06-17
Accepted Time:
2014-06-17 18:27:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1215914 E Gary Frashier C/O Achillion Pharmaceuticals, Inc.
300 George Street
New Haven CT 06511
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-16 3,750 $1.05 3,750 No 4 M Direct
Common Stock Disposition 2014-06-16 3,750 $8.00 0 No 4 S Direct
Common Stock Acquisiton 2014-06-16 16,250 $3.28 16,250 No 4 M Direct
Common Stock Disposition 2014-06-16 16,250 $8.00 0 No 4 S Direct
Common Stock Acquisiton 2014-06-16 35,000 $3.10 35,000 No 4 M Direct
Common Stock Disposition 2014-06-16 35,000 $8.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-06-16 3,750 $0.00 3,750 $1.05
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-06-16 16,250 $0.00 16,250 $3.28
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-06-16 35,000 $0.00 35,000 $3.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-15 No 4 M Direct
3,750 2019-12-18 No 4 M Direct
15,000 2020-12-16 No 4 M Direct
Footnotes
  1. This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  2. This option was granted on December 18, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  3. The option was grant on December 16, 2010 and vested as to 25% on the date of grant and as to an additional 2.08% at the end of each monthly period thereafter.